Stefano Aliberti1, Julio A Ramirez. 1. aDepartment of Health Science, University of Milan-Bicocca, Respiratory Dept, AO San Gerardo, Monza, Italy bChief, Division of Infectious Diseases and Professor of Medicine, Department of Medicine, University of Louisville, Louisville, Kentucky, USA.
Abstract
PURPOSE OF REVIEW: The aim is to evaluate basic mechanisms, prevalence, risk factors, outcomes, and potential treatments of cardiovascular events (CVEs) in patients with community-acquired pneumonia (CAP). RECENT FINDINGS: In this review, we present a new model to evaluate the pathophysiology of cardiac disease in patients with pneumonia based on plaque-related events, such as acute myocardial infarction, versus plaque-unrelated events, such as arrhythmias and heart failure. CAP increases the risk for both plaque-related and plaque-unrelated events with an absolute rate of CVE across different cohorts that varies broadly from 10 to 30%. These complications may happen among both ambulatory patients and inpatients, either on admission or during hospitalization, and/or after discharge. CVEs represent a major cause for increased mortality in CAP patients, contributing to more than 30% of deaths at long-term follow-up. SUMMARY: From a clinical perspective, especially during the first 24 h after hospitalization, CAP patients should be tested for the probability to have or develop during hospitalization a cardiac event. From a research point of view, there is an urgent need to prospectively evaluate cardioprotective interventions.
PURPOSE OF REVIEW: The aim is to evaluate basic mechanisms, prevalence, risk factors, outcomes, and potential treatments of cardiovascular events (CVEs) in patients with community-acquired pneumonia (CAP). RECENT FINDINGS: In this review, we present a new model to evaluate the pathophysiology of cardiac disease in patients with pneumonia based on plaque-related events, such as acute myocardial infarction, versus plaque-unrelated events, such as arrhythmias and heart failure. CAP increases the risk for both plaque-related and plaque-unrelated events with an absolute rate of CVE across different cohorts that varies broadly from 10 to 30%. These complications may happen among both ambulatory patients and inpatients, either on admission or during hospitalization, and/or after discharge. CVEs represent a major cause for increased mortality in CAP patients, contributing to more than 30% of deaths at long-term follow-up. SUMMARY: From a clinical perspective, especially during the first 24 h after hospitalization, CAP patients should be tested for the probability to have or develop during hospitalization a cardiac event. From a research point of view, there is an urgent need to prospectively evaluate cardioprotective interventions.
Authors: Luis F Reyes; Marcos I Restrepo; Cecilia A Hinojosa; Nilam J Soni; Antonio Anzueto; Bettina L Babu; Norberto Gonzalez-Juarbe; Alejandro H Rodriguez; Alejandro Jimenez; James D Chalmers; Stefano Aliberti; Oriol Sibila; Vicki T Winter; Jacqueline J Coalson; Luis D Giavedoni; Charles S Dela Cruz; Grant W Waterer; Martin Witzenrath; Norbert Suttorp; Peter H Dube; Carlos J Orihuela Journal: Am J Respir Crit Care Med Date: 2017-09-01 Impact factor: 21.405
Authors: Jan Gert Nel; Chrisna Durandt; Timothy J Mitchell; Charles Feldman; Ronald Anderson; Gregory R Tintinger Journal: Lung Date: 2016-05-18 Impact factor: 2.584
Authors: J G Nel; A J Theron; C Durandt; G R Tintinger; R Pool; T J Mitchell; C Feldman; R Anderson Journal: Clin Exp Immunol Date: 2016-03-02 Impact factor: 4.330
Authors: Marta Di Pasquale; Stefano Aliberti; Marco Mantero; Sonia Bianchini; Francesco Blasi Journal: Int J Mol Sci Date: 2016-02-25 Impact factor: 5.923
Authors: Stefano Aliberti; Julio Ramirez; Roberto Cosentini; Vincenzo Valenti; Antonio Voza; Paolo Rossi; Daiana Stolz; Delfino Legnani; Alberto Pesci; Luca Richeldi; Paula Peyrani; Fernando Maria Massari; Francesco Blasi Journal: ERJ Open Res Date: 2015-09-15
Authors: Ane Uranga; Jose M Quintana; Urko Aguirre; Amaia Artaraz; Rosa Diez; Silvia Pascual; Aitor Ballaz; Pedro P España Journal: PLoS One Date: 2018-02-14 Impact factor: 3.240
Authors: Stefano Aliberti; Eleonora Tobaldini; Fabio Giuliani; Vanessa Nunziata; Giovanni Casazza; Giulia Suigo; Alice D'Adda; Giulia Bonaiti; Andrea Roveda; Andreia Queiroz; Valter Monzani; Alberto Pesci; Francesco Blasi; Nicola Montano Journal: Respir Res Date: 2016-08-04